Literature DB >> 12674764

Effect of Salvia miltiorrhiza on left ventricular hypertrophy and cardiac aldosterone in spontaneously hypertensive rats.

Shaojie Han1, Zhi Zheng, Dahong Ren.   

Abstract

Chronic treatment with Salvia Miltiorrhiza preventing left ventricular hypertrophy (LVH) and its possible mechanism--inhibiting the action of cardiac aldosterone in spontaneously hypertensive rats (SHR) were investigated. Normotensive Wistar-kyoto (WKY) rats and SHRs were used. Part of SHRs was treated with Salvia Miltiorrhiza for 12 weeks. Systolic blood pressure (SBP) and left ventricular mass index were measured. Sections of heart tissue were stained with HE method and VanGieson method. Collagen volume fraction was determined in the left ventricle by automatically quantitative morphometry. Cardiac aldosterone concentration was measured by radioimmunoassay. The results indicated that compared with WKY rats, SHRs exhibited higher SBP, left ventricular collagen volume fraction, and aldosterone concentration (all P < 0.05). After the treatment with Salvia Miltiorrhiza, SBP, left ventricular collagen volume fraction, and aldosterone concentration in SHR were decreased as compared with control group (P < 0.05) except SBP. It was concluded that chronic treatment with Salvia Miltiorrhiza could prevent left ventricular hypertrophy in SHR, significantly inhibit collagen compositions in left ventricle. The mechanism was probably related with the inhibition of the cardiac aldosterone action.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12674764     DOI: 10.1007/BF02896770

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  7 in total

1.  Impaired diastolic function and coronary reserve in genetic hypertension. Role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries.

Authors:  C G Brilla; J S Janicki; K T Weber
Journal:  Circ Res       Date:  1991-07       Impact factor: 17.367

2.  Sodium-induced cardiac aldosterone synthesis causes cardiac hypertrophy.

Authors:  Y Takeda; T Yoneda; M Demura; I Miyamori; H Mabuchi
Journal:  Endocrinology       Date:  2000-05       Impact factor: 4.736

3.  Angiotensin AT1 receptor subtype as a cardiac target of aldosterone: role in aldosterone-salt-induced fibrosis.

Authors:  V Robert; C Heymes; J S Silvestre; A Sabri; B Swynghedauw; C Delcayre
Journal:  Hypertension       Date:  1999-04       Impact factor: 10.190

4.  Angiotensin II stimulates left ventricular hypertrophy in hypertensive patients independently of blood pressure.

Authors:  J Jacobi; M P Schlaich; C Delles; H P Schobel; R E Schmieder
Journal:  Am J Hypertens       Date:  1999-04       Impact factor: 2.689

Review 5.  Cardiac aldosterone production and ventricular remodeling.

Authors:  C Delcayre; J S Silvestre; A Garnier; A Oubenaissa; S Cailmail; E Tatara; B Swynghedauw; V Robert
Journal:  Kidney Int       Date:  2000-04       Impact factor: 10.612

6.  Pharmacotherapeutic effects of antihypertensive agents on myocardium and coronary arteries in hypertension.

Authors:  W Motz; M Vogt; S Scheler; B E Strauer
Journal:  Eur Heart J       Date:  1992-09       Impact factor: 29.983

7.  Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy.

Authors:  C G Brilla; J S Janicki; K T Weber
Journal:  Circulation       Date:  1991-05       Impact factor: 29.690

  7 in total
  1 in total

Review 1.  Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics.

Authors:  Zhuo-Ming Li; Suo-Wen Xu; Pei-Qing Liu
Journal:  Acta Pharmacol Sin       Date:  2018-04-26       Impact factor: 6.150

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.